- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccines as treatments for prostate cancer
Authors
Keywords
-
Journal
Nature Reviews Urology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-03-06
DOI
10.1038/s41585-023-00739-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2022) Nicholas J. Vogelzang et al. JAMA Oncology
- Preoperative Opioid Informed Consent and Prescribing Practices in Children Undergoing Orthopaedic Trauma Surgery
- (2022) Brendan A. Williams et al. Journal of the American Academy of Orthopaedic Surgeons Global Research and Reviews
- PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
- (2022) Vivek Narayan et al. NATURE MEDICINE
- ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study
- (2022) Mark N Stein et al. ONCOLOGIST
- Oral S2-Ag85 DNA Vaccine Activated Intestinal Cell dsDNA and RNA Sensors to Promote the Presentation of Intestinal Antigen
- (2022) Dang Sheng et al. Journal of Immunology Research
- Escaping Death: How Cancer Cells and Infected Cells Resist Cell-Mediated Cytotoxicity
- (2022) Karoliina Tuomela et al. Frontiers in Immunology
- Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)
- (2022) Douglas G McNeel et al. Journal for ImmunoTherapy of Cancer
- Preclinical development of a vaccine-based immunotherapy regimen (VBIR) that induces potent and durable T cell responses to tumor-associated self-antigens
- (2022) Helen Cho et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression
- (2022) Tianqi Wu et al. Cell Death & Disease
- CAR-T Cell Therapy for Solid Tumors: Are we Still That Far? a Systematic Review of Literature
- (2022) Aya Karam et al. CANCER INVESTIGATION
- Randomized phase II trial of sipuleucel-T with or without radium-223 in men with bone-metastatic castration-resistant prostate cancer
- (2021) Catherine H. Marshall et al. CLINICAL CANCER RESEARCH
- First-in-human, phase I study of PF-06753512, a vaccine-based immunotherapy regimen (PrCa VBIR), in biochemical relapse (BCR) and metastatic castration-resistant prostate cancer (mCRPC).
- (2021) Karen A. Autio et al. JOURNAL OF CLINICAL ONCOLOGY
- Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
- (2021) Oliver Sartor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer
- (2021) Charles G. Drake et al. PROSTATE CANCER AND PROSTATIC DISEASES
- IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)
- (2021) Russell K Pachynski et al. Journal for ImmunoTherapy of Cancer
- Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T
- (2021) Tanya Dorff et al. Journal for ImmunoTherapy of Cancer
- Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion
- (2021) Zhixiong Cai et al. Molecular Cancer
- Myeloid-Derived Suppressor Cells in Prostate Cancer: Present Knowledge and Future Perspectives
- (2021) Filippos Koinis et al. Cells
- Association of putative activated CD8+ T cells with modulation of rising serum PSA levels in biochemically relapsed prostate cancer patients using immunotherapy targeting prostate tumor-associated antigens: a Phase 1 study
- (2020) Neal D. Shore et al. MOLECULAR THERAPY
- Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-T
- (2020) Ravi A Madan et al. JNCI-Journal of the National Cancer Institute
- T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer
- (2020) Aleksandar Z. Obradovic et al. CLINICAL CANCER RESEARCH
- Olaparib for Metastatic Castration-Resistant Prostate Cancer
- (2020) Johann de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer
- (2020) Houssein Abdul Sater et al. Journal for ImmunoTherapy of Cancer
- Multicenter Phase 1 Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand Binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate Cancer
- (2020) Christos E. Kyriakopoulos et al. CLINICAL CANCER RESEARCH
- A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial
- (2020) Matthias Kloor et al. CLINICAL CANCER RESEARCH
- Bacterial and viral vectors as vaccine delivery vehicles for breast cancer therapy
- (2020) Balamurugan Shanmugaraj et al. LIFE SCIENCES
- Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration
- (2020) Wassim Abida et al. JOURNAL OF CLINICAL ONCOLOGY
- Vaccinia Virus Activation and Antagonism of Cytosolic DNA Sensing
- (2020) Misbah El-Jesr et al. Frontiers in Immunology
- Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings
- (2020) Horst-Dieter Hummel et al. Immunotherapy
- Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer
- (2019) James L. Gulley et al. JOURNAL OF CLINICAL ONCOLOGY
- FDA Approval Summary: Pembrolizumab for the treatment of microsatellite instability-high solid tumors
- (2019) Leigh Marcus et al. CLINICAL CANCER RESEARCH
- A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
- (2019) Liu Vaccines
- Increased indoleamine 2,3-dioxygenase activity and expression in prostate cancer following targeted immunotherapy
- (2019) Chris D. Zahm et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate Cancer
- (2019) Douglas G. McNeel et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent, but not sequential, PD-1 blockade with a DNA vaccine elicits anti-tumor responses in patients with metastatic, castration-resistant prostate cancer
- (2018) Douglas G. McNeel et al. Oncotarget
- Heterologous vaccination targeting prostatic acid phosphatase (PAP) using DNA and Listeria vaccines elicits superior anti-tumor immunity dependent on CD4+ T cells elicited by DNA priming
- (2018) Laura E. Johnson et al. OncoImmunology
- Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine
- (2018) Ellen Wargowski et al. Journal for ImmunoTherapy of Cancer
- Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report
- (2018) Cecilia Monge et al. Journal for ImmunoTherapy of Cancer
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Safety and Immunological Efficacy of a DNA Vaccine Encoding the Androgen Receptor Ligand-Binding Domain (AR-LBD)
- (2017) Brian M. Olson et al. PROSTATE
- Prostate Cancer Cells Express More Androgen Receptor (AR) Following Androgen Deprivation, Improving Recognition by AR-Specific T Cells
- (2017) Brian M. Olson et al. Cancer Immunology Research
- Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8 + T Cells
- (2017) Christopher D. Zahm et al. Cancer Immunology Research
- A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer
- (2016) Masanori Noguchi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial
- (2016) Emmanuel S. Antonarakis et al. CLINICAL CANCER RESEARCH
- Neoadjuvant therapy for localized prostate cancer: Examining mechanism of action and efficacy within the tumor
- (2016) David Y. Lou et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- A Randomized Phase II Trial of Sipuleucel-T with Concurrent versus Sequential Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer
- (2015) E. J. Small et al. CLINICAL CANCER RESEARCH
- A National Multicenter Phase 2 Study of Prostate-specific Antigen (PSA) Pox Virus Vaccine with Sequential Androgen Ablation Therapy in Patients with PSA Progression: ECOG 9802
- (2015) Robert S. DiPaola et al. EUROPEAN UROLOGY
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer
- (2015) Michal Podrazil et al. Oncotarget
- Randomized phase II trial of docetaxel with or without PSA-TRICOM vaccine in patients with castrate-resistant metastatic prostate cancer: A trial of the ECOG-ACRIN cancer research group (E1809)
- (2015) Douglas G McNeel et al. Human Vaccines & Immunotherapeutics
- PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope-Modified DNA Vaccine Immunization
- (2015) B. T. Rekoske et al. Cancer Immunology Research
- Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
- (2015) Hubert Kübler et al. Journal for ImmunoTherapy of Cancer
- Abstract 473: Long term clinical and biochemical outcomes following immunotherapy with an novel autologous immunomodulated vaccine in patients with prostate cancer.
- (2014) Fernando T. Kreutz et al. CANCER RESEARCH
- Real-Time Immune Monitoring to Guide Plasmid DNA Vaccination Schedule Targeting Prostatic Acid Phosphatase in Patients with Castration-Resistant Prostate Cancer
- (2014) D. G. McNeel et al. CLINICAL CANCER RESEARCH
- Activated Lymphocyte Recruitment Into the Tumor Microenvironment Following Preoperative Sipuleucel-T for Localized Prostate Cancer
- (2014) Lawrence Fong et al. JNCI-Journal of the National Cancer Institute
- mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer
- (2014) Steffen Rausch et al. Human Vaccines & Immunotherapeutics
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA vaccine coding for the rhesus prostate specific antigen delivered by intradermal electroporation in patients with relapsed prostate cancer
- (2013) Fredrik Eriksson et al. VACCINE
- Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer
- (2013) J. L. Gulley et al. Cancer Immunology Research
- The androgen receptor: a biologically relevant vaccine target for the treatment of prostate cancer
- (2012) Brian M. Olson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
- (2012) Hilko Ardon et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8+ T-cell responses and increases PSA doubling time
- (2012) Lindsey Chudley et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
- (2012) Alfons JM van den Eertwegh et al. LANCET ONCOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Personalized peptide vaccination: A novel immunotherapeutic approach for advanced cancer
- (2012) Tetsuro Sasada et al. Human Vaccines & Immunotherapeutics
- Castration-resistant prostate cancer: Many treatments, many options, many challenges ahead
- (2011) Jorge A. Garcia et al. CANCER
- Changes in PSA kinetics predict metastasis-free survival in men with PSA-recurrent prostate cancer treated with nonhormonal agents
- (2011) Emmanuel S. Antonarakis et al. CANCER
- Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer
- (2011) T. M. Beer et al. CLINICAL CANCER RESEARCH
- A Phase 1 Study of a Vaccine Targeting Preferentially Expressed Antigen in Melanoma and Prostate-specific Membrane Antigen in Patients With Advanced Solid Tumors
- (2011) Jeffrey S. Weber et al. JOURNAL OF IMMUNOTHERAPY
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase
- (2010) Brian M. Olson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer
- (2010) Masanori Noguchi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- DNA vaccines for the treatment of prostate cancer
- (2010) Sheeba Alam et al. Expert Review of Vaccines
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) Elicits Long-term T-cell Responses in Patients With Recurrent Prostate Cancer
- (2010) Jordan T. Becker et al. JOURNAL OF IMMUNOTHERAPY
- Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity
- (2010) Mariola Fotin-Mleczek et al. JOURNAL OF IMMUNOTHERAPY
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Cancer Vaccines in Prostate Cancer: The Paradox of Improved Survival Without Changes in Time to Progression
- (2010) R. A. Madan et al. ONCOLOGIST
- Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
- (2009) Celestia S. Higano et al. CANCER
- Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer
- (2009) Douglas G. McNeel et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunotherapy for Prostate Cancer: Walk, Don't Run
- (2009) Charles G. Drake JOURNAL OF CLINICAL ONCOLOGY
- Vaccination With Agonist Peptide PSA: 154-163 (155L) Derived From Prostate Specific Antigen Induced CD8 T-Cell Response to the Native Peptide PSA: 154-163 But Failed to Induce the Reactivity Against Tumor Targets Expressing PSA
- (2009) Diana V. Kouiavskaia et al. JOURNAL OF IMMUNOTHERAPY
- Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer
- (2008) Celestia S. Higano et al. CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now